Tretten procent af patienterne i PURSUIT blev behandlet med PCI under infusionen med eptifibatid, heraf fik cirka 50% intrakoronare stents, og 87% blev behandlet medicinsk (uden PCI under infusionen med eptifibatid).
Of the patients in PURSUIT, 13% were managed with PCI during eptifibatide infusion, of whom approximately 50% received intracoronary stents; 87% were managed medically (without PCI during eptifibatide infusion).